Caresyntax

Caresyntax is a cutting-edge startup that is revolutionizing the field of surgery with its Data-Driven Surgery approach. Founded in 2013, the company's mission is to merge AI-powered software, devices, and clinical services to enhance surgical outcomes. Caresyntax's enterprise-grade surgical intelligence system is vendor-neutral and equipped with proprietary software, hardware, and advanced AI capabilities. This system has the ability to ingest and analyze data throughout the surgical workflow, including EMR, video, audio, image, device data, financial and outcomes data, and clinical and operational metrics, thus capturing a complete picture of the surgical pathway.

The platform provides insights across the entire continuum of care, offering surgical workflow optimization before the procedure, real-time clinically relevant support tools during surgery, and clinical safety modules post-procedure. Moreover, it also generates data analytics and insights for medical device companies, insurers, and other ecosystem players, thereby driving the future of healthcare delivery.

Headquartered in the United States in San Francisco and internationally in Berlin, Caresyntax's software has made a significant impact, being utilized in over 3,000 ORs globally and aiding surgical teams in over three million procedures annually.

The company recently secured a substantial $130.00M Series C investment on 16 September 2021, with investors including Optum Ventures, Harmonix Fund, Lauxera Capital Partners, PFM Health Sciences, Relyens Innovation Santé, Rezayat Investments, surgical.ai, Arno Capital, ProAssurance, Arkin Digital Health.

In conclusion, Caresyntax is at the forefront of leveraging technology to drive advancements in surgical care, and its recent substantial investment further solidifies its position as a leader in the Analytics and Health Care industries. To learn more about Caresyntax's transformative impact on surgical care, visit www.caresyntax.com.